Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
- Resource Type
- Article
- Authors
- Javle, Milind ; Borad, Mitesh J; Azad, Nilofer S; Kurzrock, Razelle; Abou-Alfa, Ghassan K; George, Ben; Hainsworth, John; Meric-Bernstam, Funda; Swanton, Charles; Sweeney, Christopher J; Friedman, Claire F; Bose, Ron; Spigel, David R; Wang, Yong; Levy, Jonathan; Schulze, Katja; Cuchelkar, Vaikunth; Patel, Arisha; Burris, Howard
- Source
- In The Lancet Oncology September 2021 22(9):1290-1300
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045